logo
Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis
Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013
Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data
Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles
Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score
Oesophageal narrowing on barium oesophagram is more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia
Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia
Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures
Nested case–control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
Plasma interleukin-10 predicts short-term mortality of acute-on-chronic hepatitis B liver failure
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis
Editorial: unravelling the mystery of the aetiology of eosinophilic oesophagitis
Editorial: cardiac volume overload and pulmonary hypertension in long-term follow-up of TIPSS patients
Editorial: cardiac volume overload and pulmonary hypertension in long-term follow-up of TIPSS patients – authors’ reply
Editorial: autoimmune hepatitis – identifying options for treatment
Editorial: autoimmune hepatitis – identifying options for treatment. Authors’ reply
Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply
Letter: which patient profile for tacrolimus in ulcerative colitis?
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors’ reply
Letter : Helicobacter pylori infection and eosinophilic oesophagitis - causal or casual inverse association?
Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease
Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease – authors’ reply
Letter: impact of concomitant autoimmune diseases on the outcome of primary sclerosing cholangitis
Letter: deleterious effects of smoking on post-operative Crohn's disease
Letter: deleterious effects of smoking on post-operative Crohn's disease – authors’ reply
Letter: global emergence of Helicobacter pylori antibiotic resistance – unanswered questions
Letter: global emergence of Helicobacter pylori antibiotic resistance – unanswered questions. Authors’ reply
Letter: interruption of beta-blockers in patients with cirrhosis – hasten slowly!